🔬 Early Detection and Precision: Molecular and Point-of-Care Trends in the IVD Market
The In Vitro Diagnostics (IVD) Market is a critical sector dedicated to the testing of biological samples (blood, urine, tissues) outside the body to detect diseases, monitor patient health, and select appropriate therapies.
Secondly, Point-of-Care Testing (POCT) is gaining immense traction, leveraging miniaturized, portable devices (like rapid antigen tests) to deliver diagnostic results quickly at the patient's bedside, pharmacy, or home, accelerating clinical decision-making and democratizing access to testing across the In Vitro Diagnostics (IVD) Market.
Market growth is being fueled by the rising global prevalence of chronic and infectious diseases, coupled with a fundamental shift toward precision medicine.
Two major technological trends dominate the market landscape. Firstly, Molecular Diagnostics, including Next-Generation Sequencing (NGS) and Polymerase Chain Reaction (PCR), is expanding rapidly, providing highly sensitive and specific tools for detecting genetic markers, cancer mutations, and infectious pathogens.
Related Reports
- Domain
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Games
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Other
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness
- Links